CLEANING COMPOUND, ULTR

The contract calls for MAXIZYME TABLETS, an enzymatic cleaning compound specifically designed for ultrasonic cleansing in dental applications, with a unit of issue being a box containing 64 tablets. A total of three boxes are required, totaling 192 tablets, under the NSN 6520-01-655-3427, with delivery due within 20 days of award. All packaging must comply with commercial standards as outlined in the procurement document, ensuring each unit is sealed in a container that prevents damage or breakage, and that exterior shipping containers are suitable for safe, cost-effective transport via common carriers to the designated delivery point. Labeling must adhere to Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and copies of this standard are available through DLA Troop Support. The product must meet technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements, with the applicable revision controlled by the solicitation or award date. Additionally, the contract includes packaging requirements defined by RP001 and specifies the removal of government identification from non-accepted supplies under RQ011. Covered defense information may apply under RD003, and bidders must clearly identify the source and part number being supplied. The solicitation number is SPE2DH-26-T-5103, issued under NAICS code 339114 by the Department of Defense’s Medical Supply Chain FSH, with inquiries directed to Tina Vu at DLA.